Geriatric assessment is transforming genitourinary oncology by shifting treatment decisions away from chronological age and toward physiological reserve, according to discussions at the International Urology Cancer Summit (IUCS26). By evaluating frailty, function, and comorbidities, clinicians can tailor therapies to avoid both under-treatment and severe toxicity.
Moving Beyond Chronological Age in GU Oncology
Age alone fails to capture a patient’s capacity to tolerate intensive cancer therapies. According to insights shared from the International Urology Cancer Summit, chronological age often obscures true physiological resilience. Experts emphasize that old does not equal frail, requiring clinicians to actively assess patients rather than rely on birth certificates.
Vanita Noronha highlighted at the IUCS26 meeting that standard clinical evaluation must incorporate systematic screening tools. Tools such as the G8 and Mini-Cog questionnaires help identify patients who require deeper, comprehensive geriatric assessments before starting complex regimens.
Did you know? Geriatric assessments evaluate more than just physical fitness. They systematically review cognition, nutritional status, polypharmacy, and social support networks to paint a complete picture of patient vulnerability.
The Role of Comprehensive Geriatric Assessment in Treatment Decisions
Implementing structured geriatric assessments fundamentally alters treatment pathways in genitourinary oncology. According to summit presentations, these evaluations drive critical clinical choices—prompting both treatment escalation for fit older adults and safe de-intensification for vulnerable patients.
https://x.com/PGrivasMDPhD/status/2096375206789161388
Even highly effective modern regimens, such as enfortumab vedotin combined with pembrolizumab (EV+pembro), demand careful vulnerability and tolerability checks. Routine geriatric evaluations help mitigate severe treatment toxicities while preserving efficacy. Clinicians aim to align treatment with individual patient goals, balancing cure rates, quality of life, and symptom control.
Practical Steps for Clinical Integration
- Assess: Utilize screening tools like G8 and Mini-Cog to flag patients needing formal evaluation.
- Optimise: Address modifiable risk factors, including nutritional deficits and polypharmacy, prior to therapy.
- Personalise: Tailor the intensity of GU cancer regimens based on physiological reserve rather than age.
Frequently Asked Questions
Why is chronological age insufficient for GU cancer treatment planning?
Chronological age does not reflect an individual’s organ function, physiological reserve, or overall frailty.
What screening tools are recommended for older adults with cancer?
Tools like the G8 screening questionnaire and the Mini-Cog test are effective initial measures to identify older adults who will benefit from a comprehensive geriatric assessment.
https://x.com/urologysummit/status/2095865142760149401
How does geriatric assessment reduce treatment toxicity?
By identifying hidden vulnerabilities such as malnutrition, cognitive impairment, or medication overlap, clinicians can adjust dosages or select alternative regimens to prevent severe adverse events.
Join the Conversation
How is your clinic incorporating geriatric principles into oncology care? Share your thoughts in the comments below, explore related insights on OncoDaily, and subscribe to our newsletter for ongoing updates in cancer research.
Related reading